Skip to main content
All lobbying filings

DANA-FARBER CANCER INSTITUTE

Lobbying for DANA-FARBER CANCER INSTITUTE

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Expenses
$19,219
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Massachusetts

Official filing document

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 5

Funding related to biomedical and cancer research and innovation at the NIH and NCI, funding for Childhood Cancer research, funding for ARPA-H in the Labor, Health and Human Services, Education bill; funding for cancer prevention and smoking cessation programs at the CDC.

Issues related to quality of life, survivorship and access for cancer patients including HR 1509/ S 752 the Accelerating Kids Access to Care Act, HR 1262 the Give Kids a Chance Act and HR 1300/S 297 the Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act.

Issues related to health care access and reimbursement through the Medicare and Medicaid programs including site neutrality and prior authorization policies in the Medicare and Medicare Advantage program

Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including 1509/ S 752 the Accelerating Kids Access to Care Act and HR 1262 the Give Kids a Chance Act

Support for FDA's role to vigorously enforce the Family Smoking Prevention and Tobacco Control Act including the regulation of flavors, menthol and small cigars. Support for continued funding for the CDCs Office on Smoking and Health.

 Bills named in this filing 3
  • H.R. 1509
    Accelerating Kids’ Access to Care Act of 2025
  • H.R. 1262
    Mikaela Naylon Give Kids a Chance Act
  • H.R. 1300
    PSA Screening for HIM Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem